Capricor Therapeutics is trading 6.19% up now at $9.09, amid a broader market rebound.
- The gain comes during a strong September 17, 2026, risk-on session, with the S&P 500 up 0.99% and Nasdaq Composite up 1.24%.
- Growth-stock sentiment strengthened after the Federal Reserve’s September 16 rate decision.
- No new company-specific announcement clearly explains the move; recent lawsuit reminders are stale and unrelated to the intraday rebound.